Fundação Oswaldo Cruz is a
prestigious institution university
established in 1900 in Brazil. It is represented
by 832 scientists in the AD Scientific Index. The
university’s scientists are particularly concentrated in
Medical and Health Sciences (198 scientists), Natural Sciences (184 scientists), and Social Sciences and Humanities (100 scientists).
* Total H Index Rankings
Ranking Based
On Selection: 1
natural products chemistry
bioactivity
bioassays
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
50
30
0.600
* Total H Index Rankings
Ranking Based
On Selection: 2
farmacologia
química medicinal
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
39
27
0.692
* Total H Index Rankings
Ranking Based
On Selection: 3
Farmacologia
Inflamação
Produtos Naturais
Etnofarmacologia
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
24
0.923
* Total H Index Rankings
Ranking Based
On Selection: 4
Pharmacology
Drug development
Innovation
Cancer
Inflammation
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
14
0.560
* Total H Index Rankings
Ranking Based
On Selection: 5
farmácia
imunologia
farmacologia
micro/nanotecnologia
doenças infecciosas
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
19
15
0.789
* Total H Index Rankings
Ranking Based
On Selection: 6
Medicinal Chemistry
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
18
15
0.833
* Total H Index Rankings
Ranking Based
On Selection: 7
Pharmacy
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
10
0.625
* Total H Index Rankings
Ranking Based
On Selection: 8
Farmacologia
Imunologia
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
13
11
0.846
* Total H Index Rankings
Ranking Based
On Selection: 9
Pharmaceutical development and control
drug delivery systems
solid state of drugs
nanotechnology
dissolution.
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
10
9
0.900
* Total H Index Rankings
Ranking Based
On Selection: 10
Farmacologia Cardiovascular
Sistema Nervoso Simpático
Síndrome Metabólica e Microcirculação
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
9
6
0.667
* Total H Index Rankings
Ranking Based
On Selection: 11
Enzymes
Biopharmaceuticals
Biotechnology
Bioprocess
Purification
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
8
8
1.000
* Total H Index Rankings
Ranking Based
On Selection: 12
Biotechnology
biopharmaceutical
monoclonal antibody
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
8
7
0.875
* Total H Index Rankings
Ranking Based
On Selection: 13
tecnologia farmacêutica
sistemas de liberação de fármacos
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
8
7
0.875
* Total H Index Rankings
Ranking Based
On Selection: 14
Medicinal chemistry
organic synthesis
neglected diseases
pharmacologic evaluation.
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
7
6
0.857
* Total H Index Rankings
Ranking Based
On Selection: 15
pharmacy
biochemistry
molecular biology
parasitology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
6
6
1.000
* Total H Index Rankings
Ranking Based
On Selection: 16
pesquisa clínica
HIV
AIDS
farmacocinética
PK/PD
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
6
4
0.667
Carlos Leomar Zani
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
50
30
0.600
natural products chemistry
bioactivity
bioassays
Diogo Rodrigo Magalhaes Moreira
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
39
27
0.692
farmacologia
química medicinal
Jaime Ribeiro-Filho
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
24
0.923
Farmacologia
Inflamação
Produtos Naturais
Etnofarmacologia
Andre Luiz Franco Sampaio
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
14
0.560
Pharmacology
Drug development
Innovation
Cancer
Inflammation
Roberto Nicolete
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
19
15
0.789
farmácia
imunologia
farmacologia
micro/nanotecnologia
doenças infecciosas
Monica Macedo Bastos
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
18
15
0.833
Tereza Santos
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
10
0.625
Pádua,Tatiana Almeida
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
13
11
0.846
Farmacologia
Imunologia
Livia Deris Prado
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
10
9
0.900
Pharmaceutical development and control
drug delivery systems
solid state of drugs
nanotechnology
dissolution.
Alessandro Nascimento
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
9
6
0.667
Farmacologia Cardiovascular
Sistema Nervoso Simpático
Síndrome Metabólica e Microcirculação
Agnes Magri
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
8
8
1.000
Enzymes
Biopharmaceuticals
Biotechnology
Bioprocess
Purification
Fernando De Paiva Conte
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
8
7
0.875
Biotechnology
biopharmaceutical
monoclonal antibody
Thiago Frances Guimarães
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
8
7
0.875
tecnologia farmacêutica
sistemas de liberação de fármacos
Frederico Silva Castelo Branco
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
7
6
0.857
Medicinal chemistry
organic synthesis
neglected diseases
pharmacologic evaluation.
Andressa Barban Do Patrocinio
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
6
6
1.000
pharmacy
biochemistry
molecular biology
parasitology
Vitória Berg Cattani
Fundação Oswaldo Cruz
Rio de Janeiro, Brazil
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
6
4
0.667
pesquisa clínica
HIV
AIDS
farmacocinética
PK/PD